TD Asset Management Inc Sells 102,669 Shares of Encompass Health Corporation $EHC

TD Asset Management Inc cut its stake in Encompass Health Corporation (NYSE:EHC) by 10.0% during the third quarter, HoldingsChannel reports. The fund owned 923,183 shares of the company’s stock after selling 102,669 shares during the quarter. TD Asset Management Inc’s holdings in Encompass Health were worth $117,263,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in EHC. EverSource Wealth Advisors LLC boosted its holdings in shares of Encompass Health by 4.8% in the 3rd quarter. EverSource Wealth Advisors LLC now owns 4,667 shares of the company’s stock valued at $593,000 after buying an additional 213 shares in the last quarter. Vestmark Advisory Solutions Inc. boosted its stake in Encompass Health by 48.9% in the third quarter. Vestmark Advisory Solutions Inc. now owns 3,336 shares of the company’s stock valued at $424,000 after acquiring an additional 1,096 shares in the last quarter. Bleakley Financial Group LLC increased its position in shares of Encompass Health by 40.5% during the third quarter. Bleakley Financial Group LLC now owns 14,963 shares of the company’s stock worth $1,901,000 after purchasing an additional 4,310 shares in the last quarter. Premier Fund Managers Ltd purchased a new stake in shares of Encompass Health during the 3rd quarter valued at $225,000. Finally, Citigroup Inc. grew its stake in Encompass Health by 11.6% during the 3rd quarter. Citigroup Inc. now owns 53,602 shares of the company’s stock worth $6,809,000 after buying an additional 5,590 shares during the last quarter. Institutional investors own 97.25% of the company’s stock.

Insider Activity

In other news, CEO Mark J. Tarr sold 150,000 shares of the firm’s stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $111.64, for a total transaction of $16,746,000.00. Following the sale, the chief executive officer directly owned 377,070 shares in the company, valued at $42,096,094.80. This trade represents a 28.46% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 2.00% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

EHC has been the subject of several recent analyst reports. Barclays raised their price target on Encompass Health from $150.00 to $153.00 and gave the stock an “overweight” rating in a report on Friday, February 6th. Wall Street Zen upgraded shares of Encompass Health from a “hold” rating to a “buy” rating in a research note on Sunday, January 18th. Raymond James Financial raised shares of Encompass Health to a “strong-buy” rating in a report on Friday, October 31st. Finally, Zacks Research lowered Encompass Health from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, November 19th. Two equities research analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat, the stock has an average rating of “Buy” and an average target price of $143.29.

Encompass Health Stock Performance

NYSE EHC opened at $106.12 on Thursday. The firm has a market capitalization of $10.68 billion, a P/E ratio of 19.15, a PEG ratio of 1.99 and a beta of 0.73. The stock has a 50-day simple moving average of $103.84 and a two-hundred day simple moving average of $114.23. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.14 and a current ratio of 1.08. Encompass Health Corporation has a fifty-two week low of $92.53 and a fifty-two week high of $127.99.

Encompass Health (NYSE:EHC) last announced its quarterly earnings results on Thursday, February 5th. The company reported $1.46 earnings per share for the quarter, beating the consensus estimate of $1.29 by $0.17. Encompass Health had a return on equity of 18.20% and a net margin of 9.54%.The company had revenue of $3.09 billion during the quarter, compared to analysts’ expectations of $1.54 billion. During the same period last year, the business earned $1.17 earnings per share. Encompass Health’s quarterly revenue was up 9.9% on a year-over-year basis. Encompass Health has set its FY 2026 guidance at 5.810-6.100 EPS. On average, equities analysts forecast that Encompass Health Corporation will post 4.8 earnings per share for the current year.

Encompass Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 15th. Shareholders of record on Wednesday, April 1st will be given a $0.19 dividend. The ex-dividend date is Wednesday, April 1st. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.7%. Encompass Health’s dividend payout ratio is 13.72%.

Encompass Health Company Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.